Point72 Asset Management’s Orexigen Therapeutics OREX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
– Sell
-204,830
Closed -$16M – 965
2015
Q1
$16M Buy
+204,830
New +$12.7M 0.11% 241

Other funds holding OREX

Point72 Asset Management's OREX Position: Q2 2015 in Review

Point72 Asset Management sold out of Orexigen Therapeutics (OREX) in Q2 2015, closing a stake of 204,830 shares — an estimated $16M sold.

Point72 Asset Management first reported a position in OREX in Q1 2015 and held it in 1 quarter. The position peaked at $16M in Q1 2015. 161 funds tracked by Wall St. Rank hold OREX as of Q2 2015.

  • Point72 Asset Management reported no remaining Orexigen Therapeutics position as of Q2 2015 after selling out during the quarter.
  • Point72 Asset Management sold 204,830 Orexigen Therapeutics shares in Q2 2015, an estimated $16M.
  • Point72 Asset Management first reported a position in Orexigen Therapeutics in Q1 2015 and held it in 1 quarter.
  • Point72 Asset Management's Orexigen Therapeutics position peaked at $16M in Q1 2015.
  • 161 funds tracked by Wall St. Rank held Orexigen Therapeutics as of Q2 2015.

Based on Point72 Asset Management's 13F filing for Q2 2015, filed 14 Aug 2015.